Pertussis Vaccine Industry Research Report 2024
Summary
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, the global Pertussis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pertussis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
According to APO Research, the global Pertussis Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pertussis Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pertussis Vaccine include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, Wuhan Institute of Biological Products, Walvax Biotechnology, Minhai Biotechnology, KM Biologics and Chengdu Institute of Biological Products, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pertussis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pertussis Vaccine.
The report will help the Pertussis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Pertussis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pertussis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Minhai Biotechnology
- KM Biologics
- Chengdu Institute of Biological Products
- Whole-cell Vaccines
- Acellular Vaccines
- 12 Months Below
- 12 Months Above
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pertussis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pertussis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pertussis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pertussis Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pertussis Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pertussis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pertussis Vaccine Sales (2019-2030)
2.2.3 Global Pertussis Vaccine Market Average Price (2019-2030)
2.3 Pertussis Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Whole-cell Vaccines
2.3.3 Acellular Vaccines
2.4 Pertussis Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pertussis Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Pertussis Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pertussis Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pertussis Vaccine, Product Type & Application
3.8 Global Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
3.9 Global Pertussis Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pertussis Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Company Information
4.4.2 Wuhan Institute of Biological Products Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
4.4.5 Wuhan Institute of Biological Products Recent Developments
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Company Information
4.5.2 Walvax Biotechnology Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
4.5.5 Walvax Biotechnology Recent Developments
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Company Information
4.6.2 Minhai Biotechnology Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
4.6.5 Minhai Biotechnology Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 KM Biologics Pertussis Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 Chengdu Institute of Biological Products
4.8.1 Chengdu Institute of Biological Products Company Information
4.8.2 Chengdu Institute of Biological Products Business Overview
4.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
4.8.5 Chengdu Institute of Biological Products Recent Developments
5 GLOBAL PERTUSSIS VACCINE MARKET SCENARIO BY REGION
5.1 Global Pertussis Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pertussis Vaccine Sales by Region: 2019-2030
5.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
5.2.2 Global Pertussis Vaccine Sales by Region: 2025-2030
5.3 Global Pertussis Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pertussis Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pertussis Vaccine Revenue by Region: 2025-2030
5.4 North America Pertussis Vaccine Market Facts & Figures by Country
5.4.1 North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pertussis Vaccine Sales by Country (2019-2030)
5.4.3 North America Pertussis Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pertussis Vaccine Market Facts & Figures by Country
5.5.1 Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pertussis Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pertussis Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pertussis Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Pertussis Vaccine Sales by Type (2019-2030)
6.1.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pertussis Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Pertussis Vaccine Sales by Application (2019-2030)
7.1.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
7.2.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Pertussis Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pertussis Vaccine Value Chain Analysis
8.1.1 Pertussis Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pertussis Vaccine Production Mode & Process
8.2 Pertussis Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pertussis Vaccine Distributors
8.2.3 Pertussis Vaccine Customers
9 GLOBAL PERTUSSIS VACCINE ANALYZING MARKET DYNAMICS
9.1 Pertussis Vaccine Industry Trends
9.2 Pertussis Vaccine Industry Drivers
9.3 Pertussis Vaccine Industry Opportunities and Challenges
9.4 Pertussis Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Pertussis Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Pertussis Vaccine Sales (2019-2030)
2.2.3 Global Pertussis Vaccine Market Average Price (2019-2030)
2.3 Pertussis Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Whole-cell Vaccines
2.3.3 Acellular Vaccines
2.4 Pertussis Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 12 Months Below
2.4.3 12 Months Above
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Pertussis Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2019-2024)
3.3 Global Pertussis Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Pertussis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Pertussis Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Pertussis Vaccine, Product Type & Application
3.8 Global Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
3.9 Global Pertussis Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 Sanofi Pasteur
4.1.1 Sanofi Pasteur Company Information
4.1.2 Sanofi Pasteur Business Overview
4.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 Sanofi Pasteur Pertussis Vaccine Product Portfolio
4.1.5 Sanofi Pasteur Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Business Overview
4.2.3 GSK Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 GSK Pertussis Vaccine Product Portfolio
4.2.5 GSK Recent Developments
4.3 Mitsubishi Tanabe Pharma
4.3.1 Mitsubishi Tanabe Pharma Company Information
4.3.2 Mitsubishi Tanabe Pharma Business Overview
4.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
4.3.5 Mitsubishi Tanabe Pharma Recent Developments
4.4 Wuhan Institute of Biological Products
4.4.1 Wuhan Institute of Biological Products Company Information
4.4.2 Wuhan Institute of Biological Products Business Overview
4.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
4.4.5 Wuhan Institute of Biological Products Recent Developments
4.5 Walvax Biotechnology
4.5.1 Walvax Biotechnology Company Information
4.5.2 Walvax Biotechnology Business Overview
4.5.3 Walvax Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Walvax Biotechnology Pertussis Vaccine Product Portfolio
4.5.5 Walvax Biotechnology Recent Developments
4.6 Minhai Biotechnology
4.6.1 Minhai Biotechnology Company Information
4.6.2 Minhai Biotechnology Business Overview
4.6.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Minhai Biotechnology Pertussis Vaccine Product Portfolio
4.6.5 Minhai Biotechnology Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 KM Biologics Pertussis Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 Chengdu Institute of Biological Products
4.8.1 Chengdu Institute of Biological Products Company Information
4.8.2 Chengdu Institute of Biological Products Business Overview
4.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
4.8.5 Chengdu Institute of Biological Products Recent Developments
5 GLOBAL PERTUSSIS VACCINE MARKET SCENARIO BY REGION
5.1 Global Pertussis Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Pertussis Vaccine Sales by Region: 2019-2030
5.2.1 Global Pertussis Vaccine Sales by Region: 2019-2024
5.2.2 Global Pertussis Vaccine Sales by Region: 2025-2030
5.3 Global Pertussis Vaccine Revenue by Region: 2019-2030
5.3.1 Global Pertussis Vaccine Revenue by Region: 2019-2024
5.3.2 Global Pertussis Vaccine Revenue by Region: 2025-2030
5.4 North America Pertussis Vaccine Market Facts & Figures by Country
5.4.1 North America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Pertussis Vaccine Sales by Country (2019-2030)
5.4.3 North America Pertussis Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Pertussis Vaccine Market Facts & Figures by Country
5.5.1 Europe Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Pertussis Vaccine Sales by Country (2019-2030)
5.5.3 Europe Pertussis Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Pertussis Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Pertussis Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Pertussis Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Pertussis Vaccine Market Facts & Figures by Country
5.7.1 Latin America Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Pertussis Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Pertussis Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Pertussis Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Pertussis Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Pertussis Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Pertussis Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Pertussis Vaccine Sales by Type (2019-2030)
6.1.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (M Doses)
6.1.2 Global Pertussis Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Pertussis Vaccine Revenue by Type (2019-2030)
6.2.1 Global Pertussis Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Pertussis Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Pertussis Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Pertussis Vaccine Sales by Application (2019-2030)
7.1.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (M Doses)
7.1.2 Global Pertussis Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Pertussis Vaccine Revenue by Application (2019-2030)
7.2.1 Global Pertussis Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Pertussis Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Pertussis Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Pertussis Vaccine Value Chain Analysis
8.1.1 Pertussis Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Pertussis Vaccine Production Mode & Process
8.2 Pertussis Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Pertussis Vaccine Distributors
8.2.3 Pertussis Vaccine Customers
9 GLOBAL PERTUSSIS VACCINE ANALYZING MARKET DYNAMICS
9.1 Pertussis Vaccine Industry Trends
9.2 Pertussis Vaccine Industry Drivers
9.3 Pertussis Vaccine Industry Opportunities and Challenges
9.4 Pertussis Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pertussis Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Pertussis Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pertussis Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Pertussis Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pertussis Vaccine Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Pertussis Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pertussis Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Pasteur Company Information
Table 17. Sanofi Pasteur Business Overview
Table 18. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 20. Sanofi Pasteur Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. GSK Pertussis Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. Mitsubishi Tanabe Pharma Company Information
Table 27. Mitsubishi Tanabe Pharma Business Overview
Table 28. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 30. Mitsubishi Tanabe Pharma Recent Developments
Table 31. Wuhan Institute of Biological Products Company Information
Table 32. Wuhan Institute of Biological Products Business Overview
Table 33. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 35. Wuhan Institute of Biological Products Recent Developments
Table 36. Walvax Biotechnology Company Information
Table 37. Walvax Biotechnology Business Overview
Table 38. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 40. Walvax Biotechnology Recent Developments
Table 41. Minhai Biotechnology Company Information
Table 42. Minhai Biotechnology Business Overview
Table 43. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 45. Minhai Biotechnology Recent Developments
Table 46. KM Biologics Company Information
Table 47. KM Biologics Business Overview
Table 48. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. KM Biologics Pertussis Vaccine Product Portfolio
Table 50. KM Biologics Recent Developments
Table 51. Chengdu Institute of Biological Products Company Information
Table 52. Chengdu Institute of Biological Products Business Overview
Table 53. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 55. Chengdu Institute of Biological Products Recent Developments
Table 56. Global Pertussis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Global Pertussis Vaccine Sales by Region (2018-2023) & (M Doses)
Table 58. Global Pertussis Vaccine Sales Market Share by Region (2018-2023)
Table 59. Global Pertussis Vaccine Sales by Region (2024-2029) & (M Doses)
Table 60. Global Pertussis Vaccine Sales Market Share by Region (2024-2029)
Table 61. Global Pertussis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 62. Global Pertussis Vaccine Revenue Market Share by Region (2018-2023)
Table 63. Global Pertussis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 64. Global Pertussis Vaccine Revenue Market Share by Region (2024-2029)
Table 65. North America Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. North America Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 67. North America Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 68. North America Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 69. North America Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 70. Europe Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. Europe Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. Europe Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Asia Pacific Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Asia Pacific Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 77. Asia Pacific Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 78. Asia Pacific Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 79. Asia Pacific Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 80. Latin America Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Latin America Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 82. Latin America Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 83. Latin America Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. Latin America Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Middle East and Africa Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Middle East and Africa Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 87. Middle East and Africa Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 88. Middle East and Africa Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Middle East and Africa Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Global Pertussis Vaccine Sales by Type (2018-2023) & (M Doses)
Table 91. Global Pertussis Vaccine Sales by Type (2024-2029) & (M Doses)
Table 92. Global Pertussis Vaccine Sales Market Share by Type (2018-2023)
Table 93. Global Pertussis Vaccine Sales Market Share by Type (2024-2029)
Table 94. Global Pertussis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 95. Global Pertussis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 96. Global Pertussis Vaccine Revenue Market Share by Type (2018-2023)
Table 97. Global Pertussis Vaccine Revenue Market Share by Type (2024-2029)
Table 98. Global Pertussis Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 99. Global Pertussis Vaccine Price by Type (2024-2029) & (USD/Doses)
Table 100. Global Pertussis Vaccine Sales by Application (2018-2023) & (M Doses)
Table 101. Global Pertussis Vaccine Sales by Application (2024-2029) & (M Doses)
Table 102. Global Pertussis Vaccine Sales Market Share by Application (2018-2023)
Table 103. Global Pertussis Vaccine Sales Market Share by Application (2024-2029)
Table 104. Global Pertussis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 105. Global Pertussis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 106. Global Pertussis Vaccine Revenue Market Share by Application (2018-2023)
Table 107. Global Pertussis Vaccine Revenue Market Share by Application (2024-2029)
Table 108. Global Pertussis Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 109. Global Pertussis Vaccine Price by Application (2024-2029) & (USD/Doses)
Table 110. Key Raw Materials
Table 111. Raw Materials Key Suppliers
Table 112. Pertussis Vaccine Distributors List
Table 113. Pertussis Vaccine Customers List
Table 114. Pertussis Vaccine Industry Trends
Table 115. Pertussis Vaccine Industry Drivers
Table 116. Pertussis Vaccine Industry Restraints
Table 117. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Pertussis Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Pertussis Vaccine Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global Pertussis Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Pertussis Vaccine Revenue of Manufacturers (2018-2023)
Table 9. Global Pertussis Vaccine Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Pertussis Vaccine Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global Pertussis Vaccine Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Pertussis Vaccine, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pertussis Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Sanofi Pasteur Company Information
Table 17. Sanofi Pasteur Business Overview
Table 18. Sanofi Pasteur Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Sanofi Pasteur Pertussis Vaccine Product Portfolio
Table 20. Sanofi Pasteur Recent Developments
Table 21. GSK Company Information
Table 22. GSK Business Overview
Table 23. GSK Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. GSK Pertussis Vaccine Product Portfolio
Table 25. GSK Recent Developments
Table 26. Mitsubishi Tanabe Pharma Company Information
Table 27. Mitsubishi Tanabe Pharma Business Overview
Table 28. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Portfolio
Table 30. Mitsubishi Tanabe Pharma Recent Developments
Table 31. Wuhan Institute of Biological Products Company Information
Table 32. Wuhan Institute of Biological Products Business Overview
Table 33. Wuhan Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. Wuhan Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 35. Wuhan Institute of Biological Products Recent Developments
Table 36. Walvax Biotechnology Company Information
Table 37. Walvax Biotechnology Business Overview
Table 38. Walvax Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Walvax Biotechnology Pertussis Vaccine Product Portfolio
Table 40. Walvax Biotechnology Recent Developments
Table 41. Minhai Biotechnology Company Information
Table 42. Minhai Biotechnology Business Overview
Table 43. Minhai Biotechnology Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Minhai Biotechnology Pertussis Vaccine Product Portfolio
Table 45. Minhai Biotechnology Recent Developments
Table 46. KM Biologics Company Information
Table 47. KM Biologics Business Overview
Table 48. KM Biologics Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. KM Biologics Pertussis Vaccine Product Portfolio
Table 50. KM Biologics Recent Developments
Table 51. Chengdu Institute of Biological Products Company Information
Table 52. Chengdu Institute of Biological Products Business Overview
Table 53. Chengdu Institute of Biological Products Pertussis Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. Chengdu Institute of Biological Products Pertussis Vaccine Product Portfolio
Table 55. Chengdu Institute of Biological Products Recent Developments
Table 56. Global Pertussis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Global Pertussis Vaccine Sales by Region (2018-2023) & (M Doses)
Table 58. Global Pertussis Vaccine Sales Market Share by Region (2018-2023)
Table 59. Global Pertussis Vaccine Sales by Region (2024-2029) & (M Doses)
Table 60. Global Pertussis Vaccine Sales Market Share by Region (2024-2029)
Table 61. Global Pertussis Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 62. Global Pertussis Vaccine Revenue Market Share by Region (2018-2023)
Table 63. Global Pertussis Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 64. Global Pertussis Vaccine Revenue Market Share by Region (2024-2029)
Table 65. North America Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. North America Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 67. North America Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 68. North America Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 69. North America Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 70. Europe Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 72. Europe Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 73. Europe Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 75. Asia Pacific Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Asia Pacific Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 77. Asia Pacific Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 78. Asia Pacific Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 79. Asia Pacific Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 80. Latin America Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Latin America Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 82. Latin America Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 83. Latin America Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 84. Latin America Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 85. Middle East and Africa Pertussis Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Middle East and Africa Pertussis Vaccine Sales by Country (2018-2023) & (M Doses)
Table 87. Middle East and Africa Pertussis Vaccine Sales by Country (2024-2029) & (M Doses)
Table 88. Middle East and Africa Pertussis Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 89. Middle East and Africa Pertussis Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 90. Global Pertussis Vaccine Sales by Type (2018-2023) & (M Doses)
Table 91. Global Pertussis Vaccine Sales by Type (2024-2029) & (M Doses)
Table 92. Global Pertussis Vaccine Sales Market Share by Type (2018-2023)
Table 93. Global Pertussis Vaccine Sales Market Share by Type (2024-2029)
Table 94. Global Pertussis Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 95. Global Pertussis Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 96. Global Pertussis Vaccine Revenue Market Share by Type (2018-2023)
Table 97. Global Pertussis Vaccine Revenue Market Share by Type (2024-2029)
Table 98. Global Pertussis Vaccine Price by Type (2018-2023) & (USD/Doses)
Table 99. Global Pertussis Vaccine Price by Type (2024-2029) & (USD/Doses)
Table 100. Global Pertussis Vaccine Sales by Application (2018-2023) & (M Doses)
Table 101. Global Pertussis Vaccine Sales by Application (2024-2029) & (M Doses)
Table 102. Global Pertussis Vaccine Sales Market Share by Application (2018-2023)
Table 103. Global Pertussis Vaccine Sales Market Share by Application (2024-2029)
Table 104. Global Pertussis Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 105. Global Pertussis Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 106. Global Pertussis Vaccine Revenue Market Share by Application (2018-2023)
Table 107. Global Pertussis Vaccine Revenue Market Share by Application (2024-2029)
Table 108. Global Pertussis Vaccine Price by Application (2018-2023) & (USD/Doses)
Table 109. Global Pertussis Vaccine Price by Application (2024-2029) & (USD/Doses)
Table 110. Key Raw Materials
Table 111. Raw Materials Key Suppliers
Table 112. Pertussis Vaccine Distributors List
Table 113. Pertussis Vaccine Customers List
Table 114. Pertussis Vaccine Industry Trends
Table 115. Pertussis Vaccine Industry Drivers
Table 116. Pertussis Vaccine Industry Restraints
Table 117. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pertussis VaccineProduct Picture
Figure 5. Global Pertussis Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pertussis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pertussis Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Pertussis Vaccine Average Price (USD/Doses) & (2018-2029)
Figure 9. Whole-cell Vaccines Product Picture
Figure 10. Acellular Vaccines Product Picture
Figure 11. 12 Months Below Product Picture
Figure 12. 12 Months Above Product Picture
Figure 13. Global Pertussis Vaccine Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Pertussis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Pertussis Vaccine Sales by Region in 2022
Figure 20. Global Pertussis Vaccine Revenue by Region in 2022
Figure 21. North America Pertussis Vaccine Market Size by Country in 2022
Figure 22. North America Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Pertussis Vaccine Market Size by Country in 2022
Figure 27. Europe Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 28. Europe Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 29. Germany Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Pertussis Vaccine Market Size by Country in 2022
Figure 35. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 37. China Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Pertussis Vaccine Market Size by Country in 2022
Figure 47. Latin America Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Pertussis Vaccine Market Size by Country in 2022
Figure 53. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Pertussis Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Global Pertussis Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Global Pertussis Vaccine Price (USD/Doses) by Type (2018-2029)
Figure 61. Global Pertussis Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Global Pertussis Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Global Pertussis Vaccine Price (USD/Doses) by Application (2018-2029)
Figure 64. Pertussis Vaccine Value Chain
Figure 65. Pertussis Vaccine Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Pertussis Vaccine Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pertussis VaccineProduct Picture
Figure 5. Global Pertussis Vaccine Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Pertussis Vaccine Market Size (2018-2029) & (US$ Million)
Figure 7. Global Pertussis Vaccine Sales (2018-2029) & (M Doses)
Figure 8. Global Pertussis Vaccine Average Price (USD/Doses) & (2018-2029)
Figure 9. Whole-cell Vaccines Product Picture
Figure 10. Acellular Vaccines Product Picture
Figure 11. 12 Months Below Product Picture
Figure 12. 12 Months Above Product Picture
Figure 13. Global Pertussis Vaccine Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of Pertussis Vaccine, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of Pertussis Vaccine, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 Pertussis Vaccine Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global Pertussis Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global Pertussis Vaccine Sales by Region in 2022
Figure 20. Global Pertussis Vaccine Revenue by Region in 2022
Figure 21. North America Pertussis Vaccine Market Size by Country in 2022
Figure 22. North America Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Pertussis Vaccine Market Size by Country in 2022
Figure 27. Europe Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 28. Europe Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 29. Germany Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Pertussis Vaccine Market Size by Country in 2022
Figure 35. Asia Pacific Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 37. China Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America Pertussis Vaccine Market Size by Country in 2022
Figure 47. Latin America Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 48. Latin America Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa Pertussis Vaccine Market Size by Country in 2022
Figure 53. Middle East and Africa Pertussis Vaccine Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa Pertussis Vaccine Revenue Market Share by Country (2018-2029)
Figure 55. Turkey Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE Pertussis Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global Pertussis Vaccine Sales Market Share by Type (2018-2029)
Figure 59. Global Pertussis Vaccine Revenue Market Share by Type (2018-2029)
Figure 60. Global Pertussis Vaccine Price (USD/Doses) by Type (2018-2029)
Figure 61. Global Pertussis Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Global Pertussis Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Global Pertussis Vaccine Price (USD/Doses) by Application (2018-2029)
Figure 64. Pertussis Vaccine Value Chain
Figure 65. Pertussis Vaccine Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Pertussis Vaccine Industry Opportunities and Challenges
